SPRINGWORKS THERAPEUTICS INC. - COMMON STOCK
46.99
30-June-25 20:45:00
15 minutes delayed
Stocks
+0.01
+0.02%
Today's range
46.98 - 47.01
ISIN
N/A
Source
NASDAQ
-
28 Feb 2023 03:30:00 By Nasdaq GlobeNewswire
-
27 Feb 2023 03:30:00 By Nasdaq GlobeNewswire
-
09 Jan 2023 03:30:00 By Nasdaq GlobeNewswire
-
SpringWorks Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
03 Jan 2023 04:00:01 By Nasdaq GlobeNewswire
-
27 Dec 2022 03:30:07 By Nasdaq GlobeNewswire
-
SpringWorks Therapeutics to Participate in the Evercore ISI 5th Annual HealthCONx Conference
22 Nov 2022 04:00:00 By Nasdaq GlobeNewswire
-
SpringWorks Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights
03 Nov 2022 03:30:00 By Nasdaq GlobeNewswire
-
29 Sep 2022 03:30:00 By Nasdaq GlobeNewswire
-
SpringWorks Therapeutics Announces $225 Million Private Placement Financing
07 Sep 2022 06:56:00 By Nasdaq GlobeNewswire
-
07 Sep 2022 06:55:00 By Nasdaq GlobeNewswire
-
19 Aug 2022 03:30:00 By Nasdaq GlobeNewswire
-
04 Aug 2022 03:30:00 By Nasdaq GlobeNewswire
-
SpringWorks Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Conference
02 Aug 2022 04:00:01 By Nasdaq GlobeNewswire
-
SpringWorks Therapeutics Appoints Carlos Albán to its Board of Directors
15 Jul 2022 03:30:00 By Nasdaq GlobeNewswire
-
10 Jun 2022 03:30:00 By Nasdaq GlobeNewswire
-
SpringWorks Therapeutics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference
09 Jun 2022 04:00:00 By Nasdaq GlobeNewswire
-
SpringWorks Therapeutics Highlights Nirogacestat Clinical Data at the 2022 ASCO Annual Meeting
26 May 2022 14:15:00 By Nasdaq GlobeNewswire
-
24 May 2022 03:30:00 By Nasdaq GlobeNewswire
-
SpringWorks Therapeutics to Host Virtual R&D Day on June 10, 2022
16 May 2022 05:30:00 By Nasdaq GlobeNewswire